273 related articles for article (PubMed ID: 12724051)
1. Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia.
John S; Schmieder RE
Curr Hypertens Rep; 2003 Jun; 5(3):199-207. PubMed ID: 12724051
[TBL] [Abstract][Full Text] [Related]
2. Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences.
John S; Schmieder RE
J Hypertens; 2000 Apr; 18(4):363-74. PubMed ID: 10779084
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia.
Maas R; Schwedhelm E; Kahl L; Li H; Benndorf R; Lüneburg N; Förstermann U; Böger RH
Clin Chem; 2008 Feb; 54(2):292-300. PubMed ID: 18070819
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP.
Cohen RA; Vanhoutte PM
Circulation; 1995 Dec; 92(11):3337-49. PubMed ID: 7586323
[No Abstract] [Full Text] [Related]
5. Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks.
John S; Delles C; Jacobi J; Schlaich MP; Schneider M; Schmitz G; Schmieder RE
J Am Coll Cardiol; 2001 Apr; 37(5):1351-8. PubMed ID: 11300446
[TBL] [Abstract][Full Text] [Related]
6. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients.
Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
J Am Coll Cardiol; 1994 Mar; 23(4):844-50. PubMed ID: 8106688
[TBL] [Abstract][Full Text] [Related]
7. Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein e-deficient mice.
d'Uscio LV; Smith LA; Katusic ZS
Stroke; 2001 Nov; 32(11):2658-64. PubMed ID: 11692031
[TBL] [Abstract][Full Text] [Related]
8. Impaired Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Hypertensive Patients With Primary Hyperaldosteronemia: Role of 5,6,7,8-Tetrahydrobiopterin Oxidation and Endothelial Nitric Oxide Synthase Uncoupling.
Chen L; Ding ML; Wu F; He W; Li J; Zhang XY; Xie WL; Duan SZ; Xia WH; Tao J
Hypertension; 2016 Feb; 67(2):430-9. PubMed ID: 26628675
[TBL] [Abstract][Full Text] [Related]
9. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients.
Paniagua OA; Bryant MB; Panza JA
Circulation; 2001 Apr; 103(13):1752-8. PubMed ID: 11282906
[TBL] [Abstract][Full Text] [Related]
10. Protection of endothelial function: targets for nutritional and pharmacological interventions.
Sudano I; Spieker LE; Hermann F; Flammer A; Corti R; Noll G; Lüscher TF
J Cardiovasc Pharmacol; 2006; 47 Suppl 2():S136-50; discussion S172-6. PubMed ID: 16794451
[TBL] [Abstract][Full Text] [Related]
11. The role of nitric oxide on endothelial function.
Tousoulis D; Kampoli AM; Tentolouris C; Papageorgiou N; Stefanadis C
Curr Vasc Pharmacol; 2012 Jan; 10(1):4-18. PubMed ID: 22112350
[TBL] [Abstract][Full Text] [Related]
12. Primary endothelial dysfunction: atherosclerosis.
Shimokawa H
J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
[TBL] [Abstract][Full Text] [Related]
13. Effects of simvastatin and L-arginine on vasodilation, nitric oxide metabolites and endogenous NOS inhibitors in hypercholesterolemic subjects.
Pereira EC; Bertolami MC; Faludi AA; Salem M; Bersch D; Abdalla DS
Free Radic Res; 2003 May; 37(5):529-36. PubMed ID: 12797474
[TBL] [Abstract][Full Text] [Related]
14. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
Gates PE; Boucher ML; Silver AE; Monahan KD; Seals DR
J Appl Physiol (1985); 2007 Jan; 102(1):63-71. PubMed ID: 16946027
[TBL] [Abstract][Full Text] [Related]
15. Selective loss of microvascular endothelial function in human hypercholesterolemia.
Gilligan DM; Guetta V; Panza JA; García CE; Quyyumi AA; Cannon RO
Circulation; 1994 Jul; 90(1):35-41. PubMed ID: 8026018
[TBL] [Abstract][Full Text] [Related]
16. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
[TBL] [Abstract][Full Text] [Related]
17. [Arginine and statins: relationship between the nitric oxide pathway and the atherosclerosis development].
Rasmusen C; Cynober L; Couderc R
Ann Biol Clin (Paris); 2005; 63(5):443-55. PubMed ID: 16230278
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles.
Zhang C; Hein TW; Wang W; Miller MW; Fossum TW; McDonald MM; Humphrey JD; Kuo L
Hypertension; 2004 Dec; 44(6):935-43. PubMed ID: 15492130
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of nitric oxide in hypertension].
Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Demura H
Nihon Naibunpi Gakkai Zasshi; 1994 Jun; 70(5):489-502. PubMed ID: 7525365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
